Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Gossamer Bio is a clinical-stage biopharmaceutical company dedicated to discovering, acquiring, developing, and commercializing innovative therapeutic products. Our primary focus areas include immunology, inflammation, and oncology, where we aim to address significant unmet medical needs and improve patient outcomes through novel scientific approaches.
The headquarters serves as the central hub for Gossamer Bio's corporate operations, research and development activities, clinical program management, and strategic decision-making.
The facility features modern, state-of-the-art laboratory and office spaces equipped for advanced biopharmaceutical research, fostering a collaborative and innovative environment.
Gossamer Bio cultivates a dynamic and science-driven work culture characterized by rigor, collaboration, a sense of urgency, and a strong focus on patient needs. Employees are typically engaged in cutting-edge research and development within a fast-paced setting.
The San Diego headquarters is critical to Gossamer Bio's mission, housing its core scientific, clinical, and operational teams that drive the company's pipeline development and strategic growth in the competitive biotech landscape.
Gossamer Bio's global presence is primarily manifested through its clinical trial operations, which may span multiple countries across North America, Europe, and other regions, depending on the specific therapeutic programs. The company collaborates with international contract research organizations (CROs), research institutions, and investigators to conduct these trials. While its physical corporate and R&D presence is centered in the U.S., its pursuit of developing therapies for global patient populations necessitates a worldwide operational reach for clinical development and potential future commercialization.
3013 Science Park Road
San Diego
CA
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Gossamer Bio' leadership includes:
Gossamer Bio has been backed by several prominent investors over the years, including:
In the past 12 months, Gossamer Bio experienced a significant leadership change in its clinical development team with the appointment of a new Chief Medical Officer, following the departure of the former head of R&D and CMO.
Discover the tools Gossamer Bio uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Gossamer Bio typically utilizes an email format combining the first initial of an employee's first name with their complete last name, followed by the '@gossamerbio.com' domain. This is a common pattern in many biopharmaceutical companies.
f[last]@gossamerbio.com
Format
fhasnain@gossamerbio.com
Example
80%
Success rate
Gossamer Bio / GlobeNewswire • May 9, 2024
Gossamer Bio reported its financial results for the first quarter ending March 31, 2024, and provided updates on its clinical programs, including its lead candidate seralutinib for pulmonary arterial hypertension (PAH) and GB7346 for myelofibrosis....more
Gossamer Bio / GlobeNewswire • April 1, 2024
Gossamer Bio announced the appointment of Richard Aranda, M.D., Ph.D., as its new Chief Medical Officer, effective April 1, 2024. Dr. Aranda brings extensive experience in clinical development, particularly in immunology and respiratory diseases....more
Gossamer Bio / GlobeNewswire • February 29, 2024
Gossamer Bio reported its financial results for the fourth quarter and full year ended December 31, 2023, highlighting progress in its clinical pipeline, including seralutinib, and outlining strategic priorities for 2024....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Gossamer Bio, are just a search away.